@article{d7738ad0978348b28411de69678ad01a,
title = "Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021",
abstract = "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity was assessed for 3,066 individuals visiting hospitals in St. Louis, Missouri, during July 2020, November 2020, or January 2021. Seropositivity in children increased from 5.22% in July to 21.16% in January. In the same time frame, seropositivity among adults increased from 4.52% to 19.03%, prior to initiation of mass vaccination.",
keywords = "COVID-19, ELISA, SARS-CoV-2, serology, seroprevalence",
author = "Smith, {Brittany K.} and Andrew Janowski and Fremont, {Arim C.} and Adams, {Lucas J.} and Dai, {Ya Nan} and Christopher Farnsworth and Ann Gronowski and Stephen Roper and David Wang and Daved Fremont",
note = "Funding Information: This work was supported by National Institute of Allergy and Infectious Diseases collaborative agreement U01 AI151810 (D.W.) and contracts 75N93019C00062 (D.H.F.) and HHSN272201700060C (D.H.F.). A.B.J. receives support from NIAID K08 AI132745 and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award UL1 TR002345. Publisher Copyright: {\textcopyright} 2021. Smith et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license.",
year = "2021",
month = aug,
doi = "10.1128/mSphere.00450-21",
language = "English",
volume = "6",
pages = "1--5",
journal = "mSphere",
issn = "2379-5042",
number = "4",
}